Laboratory Validation for Hereditary Tyrosinemia 1 (HT1)
Estimated value
£27k
Awarded value
£27k
Awarded 25 Mar 2024
Suppliers
1
Lots
1
1 awarded
Published
23 Apr 2024
Deadline 31 Dec 2023
Description
Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories.
Scope
- Reference
- CF-2310000D0O000000rwimUAA
- Total value
- £26,523 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Feb 2024 to 30 Jul 2024
- CPV classifications
- 85111810
Submission & procedure
- Submission deadline
- 31 Dec 2023, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£27k
Award date
25 Mar 2024
Contract start
01 Feb 2024
Contract end
30 Jul 2024
Awarded to
Awarded suppliers· 1 supplier
Awarded 25 Mar 2024 · Contract period 01 Feb 2024 — 30 Jul 2024
Award value
£27k
Other contracts from NHS England
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to NHS GREATER GLASGOW AND CLYDE· 6
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| MOD Mental Health Contract | contract | — | 19 May 2026 |
| PSR - BLANKET ORDER FOR REFERRED BIOCHEMISTRY TESTS | contract | — | 06 Feb 2026 |
| Biochemistry Referrals - NHS Greater Glasgow & Clyde | contract | — | 22 May 2025 |
| Contract Title: SG9 - NHS Greater Glasgow and Clyde - Acute and Community Services | contract | — | 02 Aug 2024 |
| PPE1001182 Direct Award for the Provision of services to NHS within TLC building on the QEUH Campus | contract | — | 01 Mar 2024 |
| PPE1001181 Direct Award for the Provision of Services to NHS Within ICE Building on the QEUH Campus | contract | — | 01 Mar 2024 |